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1. Introduction 
In patients with Parkinson’s disease, cognitive impairment is common, may be detectable in 
early disease stages, even in young patients, and may progress to overt dementia. In addition, 
a variety of psychiatric and behavioural symptoms may occur in Parkinsonian patients, 
including depression, apathy, anxiety, visual hallucinations, sleep disorders, impulse control 
disorders, punding and the dopamine dysregulation syndrome. The cognitive and 
behavioural symptoms observed in these patients may be part of the non-motor symptoms of 
Parkinson’s disease, which can appear in various phases of the disease course.  
Various mechanisms might be involved in the pathogenesis of cognitive and behavioral 
symptoms in Parkinson’s disease. Cognitive and behavioural symptoms observed in 
Parkinsonian patients might be related to disruption of various circuits involving 
dopaminergic, noradrenergic, cholinergic, and serotonergic systems (Candy et al., 1983; 
Mayeux et al., 1984; Cash et al., 1987; Mattay et al., 2002). Moreover, in patients with 
Parkinson’s disease and dementia, neuropathological examination (Xuereb et al., 1990; 
Hughes et al., 1993) may show in several cortical areas the presence of Lewy Bodies (the 
histopathological hallmark of Parkinson’s disease) or neurodegenerative lesions typical of 
Alzheimer’s disease (amyloid plaques and neurofibrillary tangles). Furthermore, in patients 
with Parkinson’s disease pharmacological treatment with anti-Parkinsonian dopaminergic 
drugs may have beneficial or detrimental effects on distinct cognitive functions (Malapani et 
al., 1994; Kulisevsky et al., 1996; Mattay et al., 2002) and may also play a role in the 
development of  some behavioural disorders. 
Among the cognitive deficits which may be detected in patients with Parkinson’s disease, 
deficits of executive functions (planning, problem solving, set-shifting), mediated by 
disruption of neural circuits involving the frontal lobes and the basal ganglia, are the most 
common in both early disease phases and in patients with advanced Parkinson’s disease 
(Morris et al., 1988; Cooper et al., 1991; Robbins et al., 1994; Taylor et al., 1986; Cools et al., 
2001; Green et al., 2002).  
In addition, memory deficits (Taylor et al., 1986; Harrington et al., 1990; Cooper et al., 1991; 
Robbins et al., 1994; Dubois and Pillon, 1997), deficits of visuo-spatial cognitive functions 
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(Boller et al., 1984; Hovestadt et al., 1987; Ransmayr et al., 1987), impairment on language 
tasks of verbal fluency (Matison et al., 1982; Cooper et al., 1991) and tasks of oral naming 
(Peran et al., 2003) may occur in individual Parkinsonian patients since early phases and 
become more frequent in advanced Parkinson’s disease (Green et al., 2002).  
As to memory deficits, different studies reported in Parkinsonian patients an impairment of 
episodic memory (Taylor et al., 1986), verbal short-term memory (Cooper et al., 1991), 
spatial short-term memory (Robbins et al., 1994), and procedural memory (Harrington et al., 
1990). In patients with Parkinson’s disease and dementia, the pattern of neuropsychological 
impairment may differ in distinct patient subgroups.  
A subgroup of Parkinsonian patients, in which neurodegenerative lesions in the cerebral 
cortex seem to be less remarkable (Xuereb et al., 1990), may show a pattern of subcortical 
dementia, mainly characterized by remarkable deficits of executive functions (Litvan et al., 
1991), associated with mild to moderate deficits of episodic long-term memory (Helkala et 
al., 1988) and, in some patients, deficits of visuo-spatial cognitive functions (Mohr et al., 
1995), with relative sparing of linguistic and praxic functions (Dubois and Pillon, 1997). In 
another subgroup of patients with Parkinson’s disease and dementia, in which 
neurodegenerative lesions in the cerebral cortex are more remarkable, in addition to the 
previously described neuropsychological pattern of subcortical dementia, it is possible to 
observe a an impairment of other cognitive functions mediated by various cortical areas, 
namely an impairment of linguistic and praxic functions and severe deficits of episodic 
long-term memory (Mohr et al., 1990; Mohr et al., 1995; Marsh, 2000).  
As to psychiatric and behavioural symptoms which may be observed in patients with 
Parkinson’s disease, depression, apathy, anxiety and visual hallucinations are the most 
common manifestations. Depressive syndromes (major depression and dysthymic disorder) 
may occur in up to 45% of Parkinsonian patients (Burn, 2002). Both psychosocial and 
neurobiological factors might be involved in the pathogenesis of depressive syndromes in 
Parkinson’s disease. The role of psychosocial factors (such as a psychological reaction to 
motor disability) is suggested by studies reporting a significant correlation between severity 
of depressive symptoms and severity of motor symptoms (Gotham et al., 1986), while other 
investigations support the role of neurobiological factors such as a disruption of 
dopaminergic (Torack e Morris, 1988; Mayberg e Solomon, 1995), noradrenergic (Cubo et al., 
2000; Menza et al., 2009) and serotonergic (Paulus e Jellinger, 1991) systems, which may 
occur in early phases of Parkinson’s disease (Braak et al., 2004) and might result in the 
appearance of depressive symptoms. In some Parkinsonian patients, depressive symptoms 
may occur some years before the appearance of Parkinsonian motor symptoms, in 
agreement with the hypothesis of a critical role of neurobiological factors (Aarsland et al., 
2009).  
Apathy, which is characterised by a reduction in interest, motivation and initiative in daily 
living activities, is common in patients with Parkinson’s disease and was detected in 17% to 
70% of Parkinsonian patients in different studies (Leentjens et al., 2008; Pedersen et al., 
2009). Although the pathogenic mechanisms involved in apathy in Parkinson’s disease need 
to be further clarified, a dysfunction of the “limbic” circuit (Alexander et al., 1986) of the 
basal ganglia (which involve the ventral striatum, the anterior part of the cingulate gyrus 
and the mesial orbitofrontal cortex) might play a critical role.  
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Psychotic symptoms such as delusions and hallucinations are common in patients with 
Parkinson’s disease and may occur in up to 26% of patients (Sanchez-Ramoz et al., 1996). In 
patients with Parkinson’s disease, hallucinations and delusions may result from multiple 
pathogenic factors. Although these psychotic symptoms may be induced by the 
administration of dopaminergic anti-Parkinsonian drugs (Factor et al., 1995; Valldeoriola et 
al., 1997), they may occur also in Parkinsonian patients who do not receive any 
pharmacological treatment (Factor et al., 1995). The prevalence of hallucinations and 
delusions does increase with disease progression. Moreover, cognitive impairment is 
usually more marked in Parkinsonian patients with hallucinations as compared with 
Parkinsonian patients without hallucinations (Katzen et al., 2010). Visual hallucinations are 
the most frequent, are characterised by visions  of  people  or  animals, and are usually 
perceived as unpleasant.  
Anxiety is also common in patients with Parkinson’s disease, although epidemiological 
studies focussed on the prevalence of anxiety in these patients are still needed. In a recent 
study carried out in patients with Parkinson’s disease in early stages, the prevalence of 
anxiety was about 27% (Bugalho et al., 2012). 
Impulse control disorders (Ambermoon et al., 2011), punding and the dopamine 
dysregulation syndrome (Lim et al., 2009) have been increasingly recognized in recent years 
in patients with Parkinson’s disease.  
It has been reported that up to 13.6% of Parkinsonian patients (Weintraub et al, 2010) may 
develop behavioural changes due to a reduced impulse control (pathological gambling, 
hypersexuality, compulsive eating and buying/shopping). Such impulse control disorders 
may have dramatic implications for the personal life of the patient and for the patient’s 
family.  
In Parkinsonian patients, dopamine replacement therapy might play a role in the 
pathophysiology of impulse control disorders, by inducing an overstimulation of the 
mesolimbic dopaminergic system, which is critically involved in response to reward and 
motivation (Demetriades et al, 2011).  
It has been suggested that in patients with Parkinson’s disease the risk to develop impulse 
control disorders (Demetriades et al, 2011) may be increased by several demographic and 
clinical variables (younger age of onset of Parkinson’s disease, treatment with dopamine 
agonists, male gender, pre-existing psychiatric disorders). 
In Parkinsonian patients, the dopamine dysregulation syndrome is characterized by an 
overuse of dopaminergic anti-Parkinsonian drugs, resulting in the compulsive 
assumption of higher daily doses than those required to treat motor symptoms 
(Giovannoni et al., 2000).  
Punding is a behavioural disorder in which the patient is frequently engaged in repetitive, 
stereotyped, non-goal-oriented activities. In patients with Parkinson’s disease, punding may 
be triggered by dopaminergic anti-Parkinsonian drugs.  
Deep brain stimulation of the subthalamic nucleus  is an established neurosurgical 
procedure in the treatment of Parkinson’s disease, which may remarkably improve the 
motor symptoms and quality of life in Parkinsonian patients (Hamani et al., 2005).  
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Deep brain stimulation of the subthalamic nucleus is more effective than best medical 
therapy in improving Parkinsonian motor symptoms and dyskinesias (Hamani et al., 2005) 
and allows to obtain a long-lasting decrease of the daily doses of anti-Parkinsonian 
medications. However, a worsening of axial motor symptoms (postural instability, freezing 
of gait, difficulties in articulation of speech) may be frequently observed at long-term 
follow-up, as reported in a 8-year follow-up study carried out in 20 Parkinsonian patients 
who underwent bilateral deep brain stimulation of the subthalamic nucleus (Fasano et al., 
2010). 
While the beneficial effects of bilateral deep brain stimulation of the subthalamic nucleus  on 
motor symptoms in patients with advanced PD have been clearly analyzed by several 
studies, the effects of deep brain stimulation of the subthalamic nucleus on cognition and 
behaviour may at least partially differ among different studies and need to be further 
investigated. 
2. Cognitive performance in Parkinsonian patients treated by deep brain 
stimulation of the subthalamic nucleus  
Several investigations have assessed cognitive functioning in patients with Parkinson’s 
disease treated by deep brain stimulation of the subthalamic nucleus, with variable duration 
of postoperative follow-up in different studies. In these investigations, statistical 
comparisons were made between preoperative (baseline) performance of Parkinsonian 
patients on neuropsychological tasks and postoperative performance on the same tasks.  
Across all neuropsychological studies assessing cognitive functioning in patients with 
Parkinson’s disease treated by deep brain stimulation of the subthalamic nucleus, a 
consistently reported finding is a postoperative decline on tasks of phonological and 
semantic verbal fluency (Ardouin et al. 1999; Pillon et al. 2000, Daniele et al. 2003;  
Funkiewiez et al. 2004; Parsons et al., 2006), which was detected already few months after 
surgery in some studies and gradually increased over time in studies with long-term follow-
up (Contarino et al., 2007; Fasano et al., 2010).  
On the other hand, different studies reported less consistent findings on other cognitive 
tasks, including tasks of episodic memory and working memory and tasks assessing frontal 
cognitive functions (Parson et al., 2006). 
2.1 Performance of Parkinsonian patients treated by deep brain stimulation of the 
subthalamic nucleus on tasks of verbal fluency  
In patients affected by Parkinson’s disease who underwent deep brain stimulation of the 
subthalamic nucleus, a postoperative decline on tasks of phonological and semantic verbal 
fluency has been consistently reported by all neuropsychological investigations. Such 
decline on performance on verbal fluency tasks has been usually detected few months after 
the surgical intervention and has been observed in patients with 1-year (Pillon et al., 2000; 
Daniele et al., 2003), 3-year (Funkiewiz et al., 2004), 5-year (Contarino et al., 2007; Fasano et 
al., 2010), and 8-year follow-up (Fasano et al., 2010). A recent study aimed at assessing long-
term motor and cognitive outcome 8 years after implants for deep brain stimulation of the 
subthalamic nucleus in 20 patients with Parkinson’s disease (Fasano et al., 2010) detected a 
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decline on phonological verbal fluency task, which was slightly more pronounced 8 years 
than 5 years after surgery.  
In this study, 8 years after surgery performance on a phonological verbal fluency task could 
be assessed in 16 Parkinsonian patients. Interestingly, the analysis of raw scores (adjusted 
for age and educational level) obtained by individual Parkinsonian patients on the letter 
verbal fluency task at 8-year follow-up showed that only 2 out of 16 patients (12.5%) 
performed below the normal range and 1 patient (6.2%) scored around the cut-off score, 
while 13 out 16 patients (81.2%) performed in the normal range (Fasano et al., 2010). These 
latter findings suggest that in selected cohorts of Parkinsonian patients treated by deep 
brain stimulation of the subthalamic nucleus the statistically significant decline on verbal 
fluency tasks observed as a group effect is associated with large interindividual variability 
(Contarino et al., 2007) and in some individual Parkinsonian patients might be not 
remarkable.  
It should be pointed out that a poor performance on tasks of verbal fluency is frequently 
observed also in patients with Parkinson’s disease patients treated by pallidotomy, 
especially after left-sided pallidotomy (Troster et al., 2003) and even in patients with 
Parkinson’s disease who are not treated by neurosurgical procedures (Matison et al., 1982).  
Recently, some investigations have attempted to compare performance on verbal fluency 
tasks in two different groups of patients with Parkinson’s disease, namely patients treated 
by deep brain stimulation of the subthalamic nucleus versus Parkinsonian patients treated 
only by anti-Parkinsonian drugs (Zangaglia et al., 2009; Castelli et al., 2010; Williams et al., 
2011). Such comparative studies consistently found that performance on verbal fluency tasks 
was significantly better in Parkinsonian patients treated only by anti-Parkinsonian drugs, as 
compared to patients who underwent deep brain stimulation of the subthalamic nucleus 
and were followed-up for 6 months (Witt et al., 2008), 1 year (Castelli et al., 2010), 2 years 
(Williams et al. 2011) and 3 years (Zangaglia et al., 2009).  
In a randomized multicentre study (Witt et al., 2008), 123 patients with advanced 
Parkinson’s disease and motor fluctuations were randomly assigned to have deep brain 
stimulation of the subthalamic nucleus or the best medical treatment for Parkinson’s disease 
(according to the German Society of Neurology guidelines) and underwent 
neuropsychological and psychiatric examinations to detect possible changes 6 months after 
surgery, as compared to baseline. Sixty patients were randomly assigned to receive deep 
brain stimulation of the subthalamic nucleus and 63 patients to have best medical treatment.  
After 6 months, the group of Parkinsonian patients treated by deep brain stimulation of the 
subthalamic nucleus showed a significantly greater decline on tasks of phonological and 
semantic verbal fluency, as compared to the group of patients treated with the best medical 
treatment. These findings suggest that the impairment on verbal fluency tasks observed in 
patients who underwent subthalamic implants is not simply due to disease progression, but 
might be rather due to the neurosurgical intervention.  
In a prospective 3-year follow-up study (Zangaglia et al., 2009), 32 Parkinsonian patients 
underwent deep brain stimulation of the subthalamic nucleus, while 33 Parkinsonian 
patients, even though eligible for this surgical procedure, declined surgery and were treated 
only by anti-Parkinsonian drugs. In this latter study, as compared to the group of patients 
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treated with the best medical treatment, the group of Parkinsonian patients treated by deep 
brain stimulation of the subthalamic nucleus showed at 1-month and 3-year follow-up a 
significantly greater decline on a task of phonological verbal fluency.  
In conclusion, the postoperative decline on verbal fluency tasks in patients with Parkinson’s 
disease treated by deep brain stimulation of the subthalamic nucleus does not seem to have 
clinically meaningful effects on daily living activities, even in patients with long-term 
follow-up (Contarino et al., 2007).  
Various hypotheses have been proposed to account for the postoperative decline on tasks 
of verbal fluency observed in patients with Parkinson’s disease treated by deep brain 
stimulation of the subthalamic nucleus. On one hand, it has been suggested that the 
postoperative decline on such fluency tasks might be due to the neurosurgical procedure, 
namely to surgical microlesions affecting cortical-basal ganglionic circuits involved in 
word retrieval processes (Troster et al., 2003). This hypothesis is supported by the 
observation that the decline on verbal fluency tasks in Parkinsonian patients has been 
usually detected in very early phases after the subthalamic implant. An alternative 
hypothesis suggests that is the stimulation of the subthalamic nucleus which might lead 
to a decreased activity of various cortical areas in the left cerebral hemisphere (inferior 
frontal, insular and temporal areas), giving rise to a decreased performance on verbal 
fluency tasks (Schroeder et al. 2003).  
2.2 Performance of Parkinsonian patients treated by deep brain stimulation of the 
subthalamic nucleus on tasks of episodic memory and abstract reasoning 
As suggested by a meta-analysis on neuropsychological studies in patients with Parkinson’s 
disease treated by deep brain stimulation of the subthalamic nucleus (Parsons et al., 2006), a 
statistically significant but small decline of postoperative performance on tasks of episodic 
verbal memory has been reported in some investigations (Alegret et al., 2001; Daniele et al., 
2003; Dujardin et al., 2001; Jahanshahi et al., 2000; Pillon et al., 2000; Saint-Cyr et al., 2000; 
Trepanier et al., 2000), but not in others. Such postoperative decline on episodic verbal 
memory tasks was detectable already 3 months after surgery in some studies (Alegret et al., 
2001; Daniele et al., 2003), while in one cohort became not statistically significant at 1-year 
follow-up (Daniele et al., 2003).   
In a recent study which attempted to compare performance on various neuropsychological 
tasks in two different groups of patients with Parkinson’s disease followed-up for 12 
months, namely 105 patients treated by deep brain stimulation of the subthalamic nucleus 
versus 40 Parkinsonian patients treated only by anti-Parkinsonian drugs (Smedding et al., 
2011), performance at 6 and 12 months of postoperative follow-up on tasks of episodic 
verbal memory (immediate and delayed recall of the Rey’s Auditory Verbal Learning Test) 
was significantly poorer in Parkinsonian patients who underwent subthalamic implants,  as 
compared to patients treated only by anti-Parkinsonian drugs.  
As to studies with long-term follow-up, a statistically significant but slight decline on 
episodic verbal memory tasks (immediate and delayed recall of the Rey’s Auditory Verbal 
Learning Test) as compared to preoperative baseline was detected 8 years after subthalamic 
implants (Fasano et al., 2010).  
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However, in the cohort of 16 Parkinsonian patients followed up in such long-term study 
(Fasano et al., 2010), the analysis of individual raw scores (adjusted for age and educational 
level) showed that at 8-year follow-up on the immediate recall subtest of the Rey’s Auditory 
Verbal Learning Test only 3 out of 16 Parkinsonian patients (18.7%) performed below the 
normal range and 1 out of 16 patients (6.2%) scored around the cut-off score discriminating 
between normal and pathological performance, while 12 out of 16 patients (75%) performed 
in the normal range.  
In the same cohort, on the delayed recall subtest of the Rey’s Auditory Verbal Learning Test, 
only 3 out of 16 Parkinsonian patients (18.7%) at 8-year follow-up performed below the 
normal range, while 13 out of 16 Parkinsonian patients (81.2%) performed in the normal 
range (Fasano et al., 2010).  
These latter individual data suggest that in selected cohorts of Parkinsonian patients treated 
by deep brain stimulation of the subthalamic nucleus the statistically significant decline on 
episodic verbal memory tasks observed as a group effect is associated with a large 
interindividual variability and might be not remarkable in some individual Parkinsonian 
patients.  
A statistically significant but slight decline on a task of abstract reasoning (Raven’s 
Progressive Matrices ’47) was reported in neuropsychological studies in the same cohort of 
Parkinsonian patients treated by deep brain stimulation of the subthalamic nucleus, which 
were assessed 5 years (Contarino et al., 2007) and 8 years after surgery (Fasano et al., 2010).  
However, at 5-year follow-up the analysis of individual raw scores (adjusted for age and 
educational level) obtained by 11 individual Parkinsonian patients showed that on such task 
of abstract reasoning (Raven’s Progressive Matrices ’47) only 2 out of 11 Parkinsonian 
patients performed slightly below the normal range, while the remaining 9 patients 
performed in the normal range (Contarino et al., 2007).  
Similarly, at 8-year follow-up the analysis of the raw scores (adjusted for age and 
educational level) obtained by 16 individual Parkinsonian patients on Raven’s Progressive 
Matrices ’47 showed that only 1 out of 16 patients scored around the cut-off score, while the 
remaining 15 patients performed in the normal range (Fasano et al., 2010).  
These individual data suggest that in selected cohorts of Parkinsonian patients treated by 
deep brain stimulation of the subthalamic nucleus the statistically significant decline on 
tasks of abstract reasoning observed as a group effect at long-term follow-up might be not 
remarkable in individual Parkinsonian patients.  
2.3 Performance of Parkinsonian patients treated by deep brain stimulation of the 
subthalamic nucleus on tasks assessing cognitive functions mediated by the frontal 
lobes 
In patients with Parkinson’s disease treated by deep brain stimulation of the subthalamic 
nucleus, different effects have been described on neuropsychological tasks assessing distinct 
cognitive functions mediated by the frontal lobes.  
On one hand, various studies reported after subthalamic implants an impaired performance 
on frontal tasks assessing response inhibition, such as the interference subtest of the Stroop 
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test (Jahanshahi et al., 2000; Schroeder et al., 2002; Witt et al., 2004), in ON-stimulation 
condition as compared to the OFF-stimulation condition.  
A positron emission tomography study showed that such impaired performance on the 
interference subtest of the Stroop test in the on-stimulation condition was associated with 
decreased activation in both the right anterior cingulate cortex and the right ventral striatum 
(Schroeder et al., 2002). 
In a previously mentioned randomized multicentre study (Witt et al. , 2008) carried out in 
123 Parkinsonian patients who were randomly assigned to receive deep brain stimulation of 
the subthalamic nucleus (n =60) or to have best medical treatment (n=63), as compared to 
the best medical treatment group the group of patients treated by deep brain stimulation 
showed 6 months after surgery a significantly greater decline on several variables of the 
Stroop test. This finding might be accounted for by a dysfunction of neural circuits 
involving the basal ganglia and the frontal lobes, which might play a critical role in response 
selection (Witt et al., 2008) and response inhibition.   
On the other hand, in patients with Parkinson’s disease treated by deep brain stimulation of 
the subthalamic nucleus an improved postoperative performance has been reported in early 
phases of follow-up (6 six months after surgery) up to 26 months on neuropsychological 
frontal tasks assessing cognitive flexibility, such as the Modified Wisconsin Card Sorting 
Test (Jahanshahi et al., 2000; Daniele et al., 2003) and tasks of random number generation 
(Witt et al., 2004).  
In a neuropsychological study carried out in 20 Parkinsonian patients who underwent 
bilateral deep brain stimulation of the subthalamic nucleus (Daniele et al., 2003), patients 
were tested 3 months after surgery with stimulators switched off, while 6 and 12 months 
after surgery they were tested with stimulators switched on. In this study, an improved 
performance on a task of cognitive flexibility (Modified Wisconsin Card Sorting Test) was 
detected 6 and 12 months after surgery, when stimulators were switched on. It was 
hypothesised that such improved performance on the Modified Wisconsin Card Sorting Test 
could arise either from a genuine improvement of a specific frontal executive function such 
as cognitive flexibility (i.e. set-shifting ability) due to subthalamic implants or, alternatively, 
from a practice effect resulting from the repeated administration of the same cognitive task 
over time (Daniele et al., 2003).  
In a study carried out in 23 Parkinsonian patients who underwent bilateral deep brain 
stimulation of the subthalamic nucleus and were tested 6 to 12 months after surgery with 
stimulators switched on or off in random order (Witt et al., 2004), in the ON-stimulation 
condition there was a poorer performance on a task of response inhibition (interference 
subtest of the Stroop test) and an improved performance on a task of cognitive flexibility 
(random number generation), as compared to the OFF-stimulation condition. 
These findings are at least partially consistent with the results of a preliminary study carried 
out in 7 Parkinsonian patients treated by bilateral deep brain stimulation of the subthalamic 
nucleus (Jahanshahi et al., 2000), who were tested at variable intervals after surgery (4 to 26 
months after surgery, with a mean of 11.7 months) with stimulators switched ON or OFF in 
random order. In this latter study, in the ON-stimulation condition there was a better 
performance on tasks of cognitive flexibility (random number generation, Modified 
Wisconsin Card Sorting Test), as compared to the OFF-stimulation condition. 
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On the whole, these studies suggest that stimulation of the subthalamic nucleus might have 
different effects on distinct neural circuits involving the basal ganglia and the frontal lobes, 
resulting in a potential improvement of performance on neuropsychological tasks assessing 
cognitive flexibility (set-shifting ability) and a potential impairment of performance on 
neuropsychological tasks assessing response inhibition.  
As to studies with long-term follow-up, a statistically significant but slight decline on a task 
of cognitive flexibility (number of correct criteria discovered on the Modified Wisconsin 
Card Sorting Test) was detected 8 years after subthalamic implants, as compared to 
preoperative baseline (Fasano et al., 2010). In this study, as to the number of correct criteria 
on the Modified Wisconsin Card Sorting Test, the analysis of individual raw scores of a 
cohort of 15 Parkinsonian patients showed that at 8-year postoperative follow-up 6 out of 15 
patients (40%) performed below the normal range, while the remaining 9 patients (60%) 
performed in the normal range (Fasano et al., 2010).  
Eight years after surgery, Parkinsonian patients with a worsening of postoperative 
performance (increased number of total errors as compared to baseline) on the Modified 
Wisconsin Card Sorting Test showed significantly higher scores on items assessing postural 
stability (namely, a poorer postural stability), as compared to patients in which 
postoperative performance on the Modified Wisconsin Card Sorting Test (number of total 
errors as compared to baseline) was improved or unchanged (Fasano et al., 2010). 
As to decision-making processes, in which the subthalamic nucleus and prefrontal cortical 
areas might play a critical role, some studies reported after deep brain stimulation of the 
subthalamic nucleus (Frank et al., 2007) a reduced ability of Parkinsonian patients to slow 
down their decisions in high-conflict conditions (namely, an increased impulsivity), while 
other studies detected an improved performance on tasks of reward-based decision learning 
(VanWouve et al, 2011). 
2.4 Long-term cognitive follow-up in patients treated by deep brain stimulation of the 
subthalamic nucleus 
To summarise the results of the previously mentioned study which assessed motor and 
cognitive outcome in Parkinsonian patients 8 years after subthalamic implants (Fasano et al., 
2010), this investigation reported a statistically significant decline on a phonological verbal 
fluency task and a statistically significant but slight decline on tasks of abstract reasoning 
(Raven’s Progressive Matrices ’47), episodic verbal memory (immediate and delayed recall 
of the Rey’s Auditory Verbal Learning Test), executive functioning (number of correct 
criteria on the Modified Wisconsin Card Sorting Test).  
2.5 Prevalence of dementia in patients treated by deep brain stimulation of the 
subthalamic nucleus 
In studies implementing strict selection criteria in recruiting Parkinsonian patients for deep 
brain stimulation of the subthalamic nucleus, the prevalence of dementia was relatively low, 
even at long-term follow-up (Krack et al., 2003; Fasano et al., 2010).  
In a 5-year follow-up study, the prevalence of dementia was 6%, as 3 out of 49 patients 
developed dementia 5 years after surgery (Krack et al., 2003).  
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In the cohort of Parkinsonian patients with 8-year follow-up mentioned above (Fasano et al., 
2010), there was a 5% prevalence of dementia. In this latter study, 5 years after surgery only 
one out of 20 patients developed dementia, which had progressed at 8 years (Fasano et al., 
2010). Such prevalence rates are lower than those reported in other studies investigating less 
strictly selected Parkinsonian patients, such as one study reporting in Parkinsonian patients 
a 38% prevalence of dementia after 10 years of follow-up (Hughes et al., 2000).  
However, in one 3-year follow-up study carried out in 57 Parkinsonian patients treated by 
deep brain stimulation of the subthalamic nucleus (Aybek at al., 2007), dementia appeared 
in 5 out of 57 patients (8.7%) 6 months post surgery and in 24.5% of the patients 3 years post 
surgery, while the rest of the cohort remained cognitively stable over the whole follow-up. 
These Authors pointed out that in their cohort the prevalence of dementia over 3 years after 
deep brain stimulation of the subthalamic nucleus is similar to the prevalence reported in 
medically treated patients (Aybek at al., 2007). Moreover, in this cohort of patients treated 
by deep brain stimulation of the subthalamic nucleus some demographic and clinical 
variables (older age, presence of hallucinations, poorer performance on executive tasks) 
were preoperative risk factors of developing dementia (Aybek at al., 2007).  
The observation of a relatively high prevalence (8.7%) of dementia 6 months post surgery 
may suggest the hypothesis that less strict selection criteria were employed in this study 
(Aybek at al., 2007), as compared with other studies with long-term follow-up reporting a 
lower incidence of dementia (Krack et al., 2003; Fasano et al., 2010). 
2.6 Conclusive remarks on the effects deep brain stimulation of the subthalamic 
nucleus on cognition 
Most neuropsychological studies in Parkinsonian patients treated by deep brain stimulation 
of the subthalamic nucleus share a methodological limitation, namely the lack of a control 
group of medically-treated Parkinsonian patients, which should be matched at baseline to 
patients who undergo deep brain stimulation of the subthalamic nucleus as to various 
clinical and demographic variables (age, educational level, overall cognitive status, severity 
of motor impairment).  
Comparisons between Parkinsonian patients treated by deep brain stimulation of the 
subthalamic nucleus and medically treated Parkinsonian patients may allow to take into 
account cognitive decline due to aging and disease progression, particularly in patients with 
long-term follow-up.  
However, in most studies which recruited a control group of medically-treated 
Parkinsonian patients the follow-up was relatively short, with follow-up periods of 6 
months (Witt et al., 2008), 1 year (Castelli et al., 2010), 2 years (Williams et al., 2011) and 3 
years (Zangaglia et al., 2009). Studies recruiting a control group of medically-treated 
Parkinsonian patients with a longer follow-up period are currently needed. 
Only some neuropsychological investigations have attempted to discriminate between the 
effects on cognitive performance of the surgical intervention and the effects on cognitive 
performance of deep brain stimulation of the subthalamic nucleus itself (Jahanshahi et al., 
2000; Pillon et al., 2000; Daniele et al., 2003), by comparing cognitive performance on 
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neuropsychological tasks in different stimulation condition, namely with stimulators turned 
“ON” versus with stimulators turned “OFF”.  
In one study (Jahanshahi et al., 2000), performance on neuropsychological tasks of executive 
functions was investigated in 7 patients with Parkinson’s disease treated by deep brain 
stimulation of the subthalamic nucleus and 6 patients treated by deep brain stimulation of 
the internal globus pallidus.  Patients were assessed three times: with stimulators OFF, with 
stimulators ON, with stimulators OFF gain. With stimulators ON, in both groups of patients 
(Jahanshahi et al., 2000) there was a decline in a conditional associative learning task and an 
improved performance on several tasks assessing executive functions (Trail Making test part 
A and B, missing digit test, paced visual serial addition test, colour naming subtest of the 
Stroop Test). Moreover, with stimulators ON, only the subthalamic group showed a 
significant improvement on some additional tasks assessing executive functions (random 
number generation, Modified Wisconsin Card Sorting Test). 
In another study (Pillon et al., 2000), cognitive performance of Parkinsonian patients treated 
by deep brain stimulation of either the subthalamic nucleus or the internal globus pallidus 
was assessed postoperatively at 3 months and 12 months, in different stimulation 
conditions. In this study, the group of patients treated by subthalamic implants showed in 
ON-stimulation condition an improved cognitive performance on neuropsychological tasks 
of psychomotor speed and spatial working memory (Pillon et al., 2000).  
In patients with Parkinson’s disease, the investigation of the effects on cognition of deep 
brain stimulation of the subthalamic nucleus as compared to the internal globus pallidus is 
of remarkable importance, in order to establish the potential beneficial and detrimental 
effects of both procedures.  
In patients with Parkinson’s disease who were treated by unilateral (Vingerhoets et al., 1999) 
or bilateral (Field et al., 1999) deep brain stimulation of the internal globus pallidus, 
preliminary short-term studies with a 3-month follow-up did not detect significant 
postoperative changes in cognitive performance.  
By contrast, some investigations detected a mild decline on tasks of semantic verbal fluency 
(Volkmann et al., 2004) or executive dysfunction (Dujardin et al., 2000) in patients treated by 
bilateral deep brain stimulation of the internal globus pallidus and a mild decline on 
visuoconstructional tasks and on tasks of semantic verbal fluency in patients who 
underwent unilateral deep brain stimulation of the internal globus pallidus (Tröster et al., 
1997).  
A prospective randomized trial assessed cognition and mood in 23 patients treated by 
unilateral deep brain stimulation of the internal globus pallidus, as compared to 22 patients 
treated by unilateral deep brain stimulation of the subthalamic nucleus (Okun et al., 2009).  
In this study, a significantly greater decline on a task of phonological verbal fluency was 
detected 7 months after surgery in the group who underwent subthalamic implants, as 
compared to the group treated by deep brain stimulation of the internal globus pallidus.  
Moreover, in a multicenter long-term study carried out in 35 Parkinsonian patients treated 
by bilateral deep brain stimulation of the subthalamic nucleus and in 16 patients treated by 
bilateral deep brain stimulation of the internal globus pallidus (Moro et al., 2010), 5 to 6 
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years after surgery the occurrence of cognitive decline was higher in the group with 
subthalamic implants (23% of patients), as compared to the group with implants in the 
internal globus pallidus (12% of the patients).  
In conclusion, although cognitive morbidity after deep brain stimulation of the subthalamic 
nucleus is relatively low, deep brain stimulation of the internal globus pallidus seems to 
have even a lower cognitive morbidity and might be a safer option in Parkinsonian patients 
who are more at risk for cognitive impairment. 
3. Effects of deep brain stimulation of the subthalamic nucleus on 
behavioural symptoms 
In Parkinsonian patients treated by deep brain stimulation of the subthalamic nucleus, both 
transient behavioural symptoms (apathy, manic symptoms, hypersexuality) and persistent 
behavioural symptoms (apathy, impulse control disorders, punding, depression with 
increased suicidal tendencies in some patients) have been described. On the other hand, 
some studies reported in Parkinsonian patients treated by subthalamic implants a 
postoperative improvement of behavioural symptoms (depression, anxiety, hallucinations, 
impulse control disorders). 
3.1 Effects of deep brain stimulation of the subthalamic nucleus on mood  
3.1.1 Depressive symptoms: Clinical presentation, evolution, and pathophysiology  
After implants for deep brain stimulation of the subthalamic nucleus, some studies detected 
a postoperative improvement of depression (Daniele et al., 2003; Houeto et al., 2006; Kalteis 
et al., 2006) or no change in depressive symptoms (Drapier et al., 2006; York et al., 2008), 
while other studies reported the appearance or the worsening of depressive symptoms 
(Takeshita et al. 2005, Castelli et al., 2006; Temel et al. 2006).  
In patients with Parkinson’s disease treated by deep brain stimulation of the subthalamic 
nucleus, the proportion of subjects in which depressive symptoms appear or worsen after 
surgery as a persistent behavioural change varies between 2% up to 33%, according to 
different studies (Takeshita et al., 2005, Temel et al., 2006). Such appearance or worsening of 
depressive symptoms may be detected also in Parkinsonian patients who show a 
satisfactory postoperative improvement of motor symptoms.  
A previously mentioned long-term follow-up study in 20 consecutive Parkinsonian patients 
who received by deep brain stimulation of the subthalamic nucleus (Fasano et al., 2010) did 
not detect any significant postoperative change on scales assessing depression 8 years after 
surgery, as compared with preoperative baseline. 
In a previously mentioned prospective randomized study aimed at comparing mood in 22 
patients treated by unilateral deep brain stimulation of the subthalamic nucleus and 23 
patients treated by unilateral deep brain stimulation of the internal globus pallidus, 7 
months after surgery changes in mood did not significantly differ between the two groups 
of patients (Okun et al., 2009).  
In those Parkinsonian patients who show a postoperative improvement of depressive 
symptoms, such improvement has been interpreted as resulting either from a psychological 
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response to the amelioration of Parkinsonian motor symptoms (Jahanshahi et al., 2000) or to 
the effects of deep brain stimulation of the subthalamic nucleus on neural systems which 
play a role in mood (Romito et al., 2002).  
It has been hypothesized that in Parkinsonian patients treated with subthalamic implants 
postoperative depression might result either from the reduction of daily doses of 
dopaminergic drugs (Giovannoni et al, 2000) or from an indirect inhibition of the activity of 
serotonergic neurons in the dorsal raphe nuclei induced by deep brain stimulation of the 
subthalamic nucleus (Temel et al., 2007), possibly through various structures (ventral 
pallidum, substantia nigra pars reticulata, medial prefrontal cortex) which directly project to 
dorsal raphe nuclei (Tan et al., 2001). 
3.1.2 Depressive symptoms: Treatment and prognosis  
After deep brain stimulation of the subthalamic nucleus, suicidal tendencies have been 
reported in some Parkinsonian patients (Soulas et al., 2008; Voon et al., 2008).  
In a retrospective survey carried out in 5311 Parkinsonian patients treated with subthalamic 
implants (Voon et al., 2008) the rate of completed suicide was 0.45%, while the rate of 
attempted suicide was 0.90%. In this study, an increased risk of attempted suicide was 
associated with a number of factors (postoperative depression, previous history of impulse 
control disorders or compulsive medication use, being single) and the highest rate of 
suicides was detected in the first postoperative year.  
In another retrospective survey carried out in a smaller sample (n = 200) of Parkinsonian 
patients who underwent subthalamic implants (Soulas et al., 2008), despite a remarkable 
motor improvement, there was a higher than expected frequency of suicide (1% of 
completed suicide, 2% of attempted suicide) and suicidal behaviour was associated with 
postoperative depression and altered impulse control.  
These latter studies (Soulas et al., 2008; Voon et al., 2008) show that there might be an 
increased risk of suicidal behaviour in Parkinsonian patients treated with subthalamic 
implants, suggesting that the main risk factor for attempted and completed suicide is 
postsurgical depression, which on postoperative follow-up should be adequately diagnosed 
and treated with anti-depressant drugs.  
3.1.3 Manic symptoms: Clinical presentation, evolution, and pathophysiology  
A systematic review of a large sample (n = 1398) of Parkinsonian patients who underwent 
bilateral brain stimulation of the subthalamic nucleus showed that the occurrence of manic 
symptoms was reported in about 4% of PD patients (Temel et al., 2006), more frequently 
early after surgery (Romito et al., 2002; Schupbach et al., 2005; Visser-Vandewalle et al., 
2005; Contarino et al., 2007).  
Manic symptoms in patients treated by subthalamic implants mostly last few hours or few 
days and are usually observed after stimulation of contacts in the ventral part of the substantia 
nigra, probably in the substantia nigra pars reticulata (Ulla et al., 2006; Ulla et al., 2011).  
In some patients, however, manic symptoms might be induced by stimulation of contacts 
within the subthalamic nucleus (Ulla et al., 2011; Mallet et al., 2007), especially by 
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stimulation of a ventral contact of the electrode within the subthalamic nucleus. In these 
cases, manic symptoms may disappear by switching off this ventral contact (Mallet et al. 
2007). It has been also suggested that stimulation of axons projecting from medial (limbic) 
subthalamic nucleus to the medial forebrain bundle might give rise to transient reversible 
hypomania (Coenen et al., 2009).  
In Parkinsonian patients who show stimulation-induced manic symptoms after subthalamic 
implants (Ulla et al., 2011), positron emission tomography showed during the manic state an 
increase of regional cerebral blood flow in various structures (anterior cingulate cortex, the 
medial prefrontal cortex, primary motor cortex, globus pallidus), mainly in the right cerebral 
hemisphere.  
These findings support the hypothesis that a dysfunction of limbic structures (particularly, 
the anterior cingulate cortex and the medial prefrontal cortex) in the right cerebral 
hemisphere, induced by stimulation of the substantia nigra or the subthalamic nucleus, 
might play a critical role in the pathophysiology of manic states induced by subthalamic 
implants in Parkinsonian patients.  
3.1.4 Manic symptoms: Treatment and prognosis 
In Parkinsonian patients, manic symptoms may disappear after switching to other targets to 
be stimulated (Raucher-Chene et al., 2008) or readjusting the parameters of stimulation 
(Mandat et al., 2006). 
3.2 Effects of deep brain stimulation of the subthalamic nucleus on apathy  
3.2.1 Apathy: Clinical presentation, evolution, and pathophysiology  
Apathy, which may be defined as loss of motivation (Marin, 1991), is a common behavioural 
symptom in patients with Parkinson’s disease.  
Most studies assessing apathy before and after surgery in Parkinsonian patients treated by 
subthalamic implants found a postoperative worsening of apathy (Funkiewiez et al., 2004; 
Schupbach et al., 2005; Drapier et al., 2006; Contarino et al., 2007; Le Jeune et al., 2009; Porat 
et al., 2009; Thobois et al., 2010), while two studies found no postoperative change in apathy 
(Castelli et al., 2006; Castelli et al., 2007). By contrast, in Parkinsonian patients who 
underwent bilateral deep brain stimulation of the subthalamic nucleus a transient 
improvement of apathy was detected after acute subthalamic stimulation, namely in ON 
stimulation as compared to OFF stimulation condition (Czernecki et al., 2005). To our 
knowledge, no study reported in Parkinsonian patients a significant improvement of 
chronic apathy following subthalamic implants.  
It has been reported that after subthalamic implants a postoperative worsening of apathy 
may occur in the absence of significant postoperative changes of depression or anxiety 
(Drapier et al., 2006).  
In a recent study (Kirsh-Darrow et al., 2011), apathy was assessed in Parkinsonian patients 
who underwent either unilateral deep brain stimulation of the internal globus pallidus (n = 
15) or unilateral deep brain stimulation of the subthalamic nucleus (n = 33) and in a control 
group of medically treated Parkinsonian patients (n = 48). The results of this study show 
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that apathy progressively increased up to 6 months after both subthalamic and pallidal 
unilateral implants, while it was unchanged in the non-surgical group of Parkinsonian 
patients (Kirsh-Darrow et al., 2011). In this study, the degree of apathy in patients who 
underwent deep brain stimulation was not related to postsurgical changes in levodopa 
equivalent daily doses (Kirsh-Darrow et al., 2011).  
In a prospective study focused on the occurrence of apathy and associated symptoms in 63 
patients with Parkinson's disease treated with deep brain stimulation of the subthalamic 
nucleus (Thobois et al., 2010), apathy appeared in 34 patients after a mean of 4.7 months and 
was reversible in 17 patients by the 12-month follow-up.  
In this study, [11C]-raclopride positron emission tomography showed that binding values 
were greater in apathetic Parkinsonian patients in various structures (orbitofrontal, 
dorsolateral prefrontal, posterior cingulate and temporal cortices, left striatum and right 
amygdala) bilaterally, suggesting a greater dopamine D2/D3 receptor density or reduced 
synaptic dopamine level in such structures.  
3.2.2 Apathy: Treatment and prognosis  
The effects of a 6-week treatment with the dopamine D2-D3 agonist ropinirole was 
investigated in 8 Parkinsonian patients who developed apathy after complete withdrawal 
from dopaminergic medication, following successful subthalamic implants (Czernecki et al., 
2008). In 7 out of 8 Parkinsonian patients (in which the stimulation contacts were located 
within the subthalamic nucleus), ropinirole induced an improvement of apathy, while only 
one patient (in whom the stimulation contacts were located within the zona incerta) 
remained apathetic. This study suggests that in Parkinsonian patients treated by 
subthalamic implants apathy may result from a dopaminergic deficiency in associative 
limbic areas and can be effectively treated in most patients by dopaminergic agonists 
administered postoperatively (Czernecki et al., 2008).  
3.3 Effects of deep brain stimulation of the subthalamic nucleus on anxiety  
3.3.1 Anxiety: Clinical presentation, evolution, and pathophysiology  
After subthalamic implants, a number of studies showed in Parkinsonian patients a 
postoperative improvement of anxiety (Daniele et al., 2003; Houeto et al., 2006; Kalteis et al., 
2006; Schupbach et al., 2007) or no change in anxiety symptoms (Drapier et al. , 2006; York et 
al., 2008), while other studies reported the appearance or the worsening of anxiety 
(Rodriguez-Oroz et al. 2005; Castelli et al., 2006).   
The postoperative improvement of anxiety observed in some studies might result from the 
beneficial effects of subthalamic implants on the motor symptoms of Parkinson’disease 
(Daniele et al., 2003).  
On the other hand, in Parkinsonian patients treated by subthalamic implants, in which a 
marked reduction of daily doses of dopaminergic drugs is usually obtained postoperatively, 
it has been hypothesized that a postoperative worsening of anxiety might result from a 
delayed dopamine withdrawal syndrome (Thobois et al., 2010). 
In Parkinsonian patients, individual differences in both dopaminergic treatment and in the 
extent of denervation of dopaminergic mesolimbic systems might explain the variable 
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effects of deep brain stimulation of the subthalamic nucleus on anxiety, mood and 
motivation/apathy (Thobois et al., 2010). 
3.3.2 Anxiety: Treatment and prognosis 
So far, the issue of treatment of anxiety symptoms in Parkinsonian patients who undergo 
subthalamic implants has been poorly investigated.  
In a study with a 6-month follow-up period in which patients were randomly assigned to have 
subthalamic implants (n = 63) or the best medical treatment for Parkinson’s disease (n = 60), 
anxiety was reduced in the subthalamic implant group, as compared with the medically-
treated group (Witt et al., 2008). In a long-term follow-up study in 20 Parkinsonian patients 
who received subthalamic implants, 8 years after surgery no significant change was observed 
on a scale assessing anxiety, as compared with baseline (Fasano et al., 2010).  
3.4 Effects of deep brain stimulation of the subthalamic nucleus on psychotic 
symptoms 
3.4.1 Psychotic symptoms: Clinical presentation, evolution, and pathophysiology  
In Parkinsonian patients treated by bilateral subthalamic implants, hallucinations and 
delusions may appear as transient behavioural symptoms shortly after surgery (Romito et 
al., 2002).  
It is still matter of debate whether Parkinsonian patients with history of hallucination may 
be good candidates for subthalamic implants.  
A retrospective review of 10 Parkinsonian patients who suffered from severe medication-
induced hallucinations or delusions and underwent bilateral subthalamic implants 
(Umemura et al., 2011) showed that such psychotic symptoms disappeared in 8 out of 10 
patients after postoperative reduction of dopaminergic medication. By contrast, in 2 out of 
10 patients hallucinations and delusions worsened immediately after surgery (despite 
complete withdrawal of dopaminergic medication), but disappeared after treatment with 
anti-psychotic drugs for some months (Umemura et al., 2011). On the whole, such 
retrospective review suggests that deep brain stimulation of the subthalamic nucleus is a 
good treatment option in Parkinsonian patients with medication-induced hallucinations or 
delusions, provided that the possible worsening of psychotic symptoms which may be 
observed in a subgroup of patients is carefully monitored and treated. 
In a further study aimed at assessing the effects of subthalamic implants on preexisting 
hallucinations in 18 patients with advanced Parkinson’s disease (Yoshida et al., 2009), six 
months after the implant there was a significant postoperative improvement of severity of 
hallucinations, as compared with baseline.  
These latter studies (Umemura et al., 2011; Yoshida et al., 2009) suggest that in patients with 
advanced Parkinson’s disease a history of hallucinations is not a contraindication to 
subthalamic implants.  
In conclusion, it might be hypothesized that in most Parkinsonian patients with medication-
induced hallucinations a postoperative reduction of dopaminergic anti-Parkinsonian drugs 
might play a critical role in the postoperative improvement of hallucinations. 
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3.4.2 Psychotic symptoms: Treatment and prognosis 
As mentioned above, treatment with anti-psychotic drugs is indicated in Parkinsonian 
patients in whom hallucinations and delusions worsen immediately after surgery 
(Umemura et al., 2011). In a group of Parkinsonian patients followed up for 3 years after 
deep brain stimulation of the subthalamic nucleus, the use of antipsychotic drugs was stable 
until 1 year, while there was a subsequent increase in the use of antipsychotic drugs at 3 
years (Zibetti et al., 2009). 
3.5 Effects of deep brain stimulation of the subthalamic nucleus on impulse control 
disorders  
3.5.1 Impulse control disorders: Clinical presentation, evolution, and pathophysiology  
In Parkinsonian patients treated by deep brain stimulation of the subthalamic nucleus, 
impulse control disorders (pathological gambling, hypersexuality, compulsive eating and 
buying/shopping) may occasionally appear after surgery, while in most cases preexisting 
impulse control disorders may improve or disappear after subthalamic implants (Broen et 
al., 2011; Witjas et al., 2005; Bandini et al., 2007; Ardouin et al., 2006; Lim et al., 2009).  
As to pathological gambling (Lim et al., 2009) and hypersexuality (Doshi & Bargava, 2008), 
these disorders may be occasionally be observed in some Parkinsonian patients after 
subthalamic implants, while Parkinsonian patients may rarely develop compulsive eating 
after subthalamic implants (Zahodne et al., 2011). A weight gain, which may result from 
multiple pathogenic factors besides compulsive eating, may be detected in up 48% of 
Parkinsonian patients after deep brain stimulation of the subthalamic nucleus (Piboolnurak 
et al., 2007). 
In Parkinsonian patients who show a postoperative improvement of preexisting impulse 
control disorders, such improvement might be due to at least two mechanisms. The most 
plausible mechanism is a reduction of dopaminergic medication after the subthalamic 
implants, which leads to decreased stimulation of mesolimbic dopaminergic circuits 
(Ardouin et al., 2006). Alternatively, it has been proposed that deep brain stimulation of the 
subthalamic nucleus may induce inhibitory effects on dopaminergic and serotoninergic 
pathways ascending to limbic circuits involved in reward (Witjas et al., 2005).  
On the other hand, in some Parkinsonian patients, impulse control disorders appear after 
subthalamic implants, notwithstanding with a postoperative reduction of doses of 
dopaminergic drugs (Romito et al., 2002; Doshi and Bargava, 2008; Smeding et al., 2007; 
Sensi et al., 2004; Lim et al., 2009). In these latter patients, it might be hypothesised that deep 
brain stimulation of the subthalamic nucleus may induce changes in the activity of limbic 
circuits involving the subthalamic nucleus or involving fibres adjacent to this nucleus, 
giving rise to a tendency to impulsivity (Demetriades et al, 2011). A neurophysiological 
study aimed at recording local field potentials in the subthalamic nucleus of Parkinsonian 
patients patients treated by deep brain stimulation of the subthalamic nucleus (Rodriguez-
Oroz et al., 2011) showed an oscillatory theta-alpha activity in the ventral subthalamic 
nucleus, which was associated with impulse control disorders, suggesting that such limbic 
ventral subthalamic area might be involved in the development of impulse control disorders 
in these Parkinsonian patients. 
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It has been previously mentioned that the subthalamic nucleus and prefrontal cortical areas 
might play a critical role in decision-making processes and that patients with Parkinson’s 
disease may show after deep brain stimulation of the subthalamic nucleus a reduced ability 
to slow down their decisions in high-conflict conditions, resulting in increased impulsivity 
(Frank et al., 2007).  
3.5.2 Impulse control disorders: Treatment and prognosis 
In a cross-sectional study aimed at comparing Parkinsonian patients treated by subthalamic 
implants versus Parkinsonian patients treated by anti-Parkinsonian drugs but eligible for deep 
brain stimulation (Halbig et al. , 2009), impulsivity was assessed by the Barratt Impulsiveness 
Scale and was higher in patients with subthalamic implants. In this study, the prevalence of 
impulse control disorders was higher (3 out of 16 subjects, namely 19%) in patients treated by 
subthalamic implants than in medically treated Parkinsonian patients (3 out of 37 subjects, 
namely 8%). The Authors suggest that screening for impulsivity and impulse control disorders 
should be performed prior to deep brain stimulation (Halbig et al. , 2009).  
In conclusion, since the effects of brain stimulation of the subthalamic nucleus on impulse 
control disorders in Parkinsonian patients are variable, the prognosis of such disorders may 
vary from patient to patient, although in most Parkinsonian patients preexisting impulse 
control disorders may improve or disappear after subthalamic implants. Further studies are 
needed in order to clarify the issue of treatment strategies in those patients in whom 
impulse control disorders do appear or worsen after surgery. 
3.6 Long-term behavioural follow-up in patients treated by deep brain stimulation of 
the subthalamic nucleus 
In the previously mentioned study assessing motor and cognitive outcome in patients with 
Parkinson’s disease 8 years after subthalamic implants (Fasano et al., 2010), in the overall 
group of patients there was no significant change 8 years after surgery on behavioural scales 
assessing depression and anxiety, as compared to preoperative baseline. In the cohort of 20 
Parkinsonian patients who completed the 8-year follow-up (Fasano et al., 2010), a number of 
persistent behavioral adverse events were reported, such as depressive symptoms (in 25% of 
the patients), apathy (in 20% of the patients), psychotic symptoms (in 20% of the patients), 
hypersexuality (in 5% of the patients).  
3.7 An explicative case of a Parkinsonian patient with manic symptoms after bilateral 
subthalamic implants 
A 52-year-old right-handed man presented a 11-year history of severe rigid–akinetic 
Parkinson’s disease, which became poorly responsive to anti-Parkinsonian medication 
(Romito et al., 2002). This patient, who had a family history of major depression, at the age 
of 26 years suffered from a major depressive episode, during his father’s terminal illness.  
The patient received a implant of quadripolar leads bilaterally in the subthalamic nucleus 
under stereotactic guidance. Compared to preoperative assessment, he showed a marked 
improvement of Parkinsonian motor symptoms and activities of daily living, while wearing-
off phenomena and on-state dyskinesias (reported before the implantation) disappeared. 
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Two days after the implant, the patient developed a manic syndrome (Romito et al., 2002), 
characterized by inflated self-esteem and grandiosity, marked increase in goal-directed 
activities, need to purchase unneeded items, decreased need for sleep, planning of 
hazardous business investments, flights of ideas. His appetite decreased and the patient lost 
5 to 6 kg. Sexual desire and sexual activity increased and the patient had frequent 
spontaneous erections, although he was not on dopamine agonists. Despite a lack of interest 
in religion, he started to spend much time in writing poems on religious themes. Moreover, 
the patient became irritable, litigious, and over-reactive. A diagnosis of manic episode was 
made.  
When the stimulator was turned off, there was a rapid worsening of Parkinsonian motor 
symptoms but manic symptoms did not improve (Romito et al., 2002).  
In this patient, all antiparkinsonian medication was discontinued 1 month after surgery. 
Stimulation settings remained unchanged from the second month on. During postoperative 
follow-up up to 12 months after surgery, he showed no significant change in cognitive 
performance on neuropsychological tasks, as compared to preoperative performance.  
In agreement with his wife, the patient was followed up very carefully, but no 
pharmacological treatment for manic symptoms was prescribed. Three months after their 
onset, manic symptoms gradually decreased and then disappeared completely. Twelve 
months after the subthalamic implant, the patient showed a slight reduction of initiative, in 
the absence of any significant impairment in daily living activities (Romito et al., 2002). 
4. Conclusions 
Cognitive and behavioural disturbances in patients with Parkinson’s disease seem to be 
relatively more frequent after deep brain stimulation of the subthalamic nucleus, as 
compared with deep brain stimulation of the internal globus pallidus. This finding might be 
at least partially due to the fact that the subthalamic nucleus is a smaller target, with 
different neural circuits (motor, associative, and limbic circuits) in close proximity to each 
other. Thus, electrode misplacements or current spreading to non-motor circuits involving 
the subthalamic nucleus may give rise to cognitive and behavioural disturbances after 
subthalamic implants. 
On the whole, nonetheless, most studies agree about the view that the cognitive and 
behavioural morbidity of deep brain stimulation of the subthalamic nucleus in patients with 
Parkinson’s disease can be considered relatively low, even in the long term, provided that 
appropriate criteria are used to select candidates for neurosurgery,  
Further studies are certainly needed to elucidate the pathophysiological mechanisms 
underlying the postoperative cognitive and behavioural changes which may be observed in 
Parkinsonian patients treated by deep brain stimulation of the subthalamic nucleus. 
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